SK Biopharmaceuticals

SK Biopharmaceuticals

World Rank (Jan-05-2024)
2,458
Market Cap (Jan-05-2024)
6.236 Billion USD
World Rank (Jul-30-2023)
2,963
Market Cap (Jul-30-2023)
5.022 Billion USD
World Rank (Jan-07-2022)
2,773
Market Cap (Jan-07-2022)
6.172 Billion USD
World Rank (Jan-01-2021)
1,483
Market Cap (Jan-01-2021)
11.780 Billion USD
Headquarters Country
South Korea
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
189 Million USD
Annual Operating Income in USD
-101 Million USD
Annual Net Income in USD
-107 Million USD
Annual Results for Period Ending
Dec-2022 ending period
Total Assets in USD
511 Million USD
Total Liabilities in USD
267 Million USD
Total Equity in USD
243 Million USD
Balance Sheet for Period Ending
Dec-2022 ending period
Business Sector
Healthcare
Biopharmaceutical
Biotechnology
Company Website
SK BIOPHARMACEUTICALS
Yahoo
Yahoo @ SouthKorea
Company Profile

SK Biopharmaceuticals is a Biopharmaceutical company that develops new drugs in support of innovations in the medical field. The headquarters is in South Korea.

Founded Year
2011

Share